Results 31 to 40 of about 874,057 (168)

Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma. [PDF]

open access: yesArthritis Care Res (Hoboken), 2017
ObjectiveLocalized scleroderma can negatively affect children's quality of life (QoL), but predictors of impact have not been well described. We sought to identify predictors of QoL impact in juvenile localized scleroderma patients.MethodsWe analyzed longitudinal data from a single‐center cohort of juvenile localized scleroderma patients, using ...
Ardalan K, Zigler CK, Torok KS.
europepmc   +4 more sources

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies [PDF]

open access: yesPediatric Rheumatology Online Journal, 2012
Li Suzanne C   +12 more
doaj   +2 more sources

Localized scleroderma in children

open access: yesPrzegląd Dermatologiczny, 2020
Localized scleroderma is an autoimmune disease affecting the dermis and underlying tissues (subcutaneous tissue, fascia, muscles, bones). The disease mainly occurs in women aged 20–50 years; however, children aged 7–10 years represent about 15% of all ...
Katarzyna A. Wolska-Gawron   +1 more
doaj   +1 more source

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma [PDF]

open access: yesPediatric Rheumatology Online Journal, 2008
Osminina MK   +4 more
doaj   +2 more sources

Research Progress on Pathogenesis and Treatment of Juvenile Localized Scleroderma

open access: yesXiehe Yixue Zazhi, 2022
Juvenile localized scleroderma (JLS) is a rare autoimmune disease in children. The lack of specificity in the early symptoms of JLS makes it easy to be misdiagnosed and missed, which leads to the continuous progression of the lesions, and even causes ...
YANG Jingyi, XU Qianyue, YU Hong
doaj   +1 more source

Neurological and psychological aspects of scleroderma of the face and neck in children

open access: yesЛечащий Врач, 2021
In the structure of morbidity, among rheumatic diseases in children, juvenile scleroderma takes the third place in frequency after juvenile idiopathic arthritis and systemic lupus erythematosus.
M. S. Pavlova   +9 more
doaj   +1 more source

Juvenile localized scleroderma

open access: yesSri Lanka Journal of Child Health, 2019
No abstract available Sri Lanka Journal of Child Health, 2019; 48(4): 364 ...
Luis Zavaleta-Medina   +4 more
openaire   +2 more sources

Juvenile localized scleroderma: clinical picture, diagnosis, therapeutic update (literature review and own observations)

open access: yesZdorovʹe Rebenka, 2019
Among rheumatic diseases in children, a special place belongs to juvenile localized scleroderma, which is highlighted as a separate form in the structure of scleroderma diseases and is characterized by: the onset of the disease up to 16 years, skin ...
L.F. Bogmat, V.V. Nikonova
doaj   +1 more source

Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma

open access: yesJournal of Ultrasonography, 2020
Scleroderma is a rare, autoimmune, chronic condition that affects the connective tissue by excessive collagen production. If diagnosed before the age of 16, it is referred to as juvenile scleroderma.
Idzior Marta   +4 more
doaj   +1 more source

Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil

open access: yes, 2009
To evaluate the efficacy of mycophenolate mofetil (MMF) in the treatment of severe refractory juvenile localized scleroderma (JLS)
Martini, Giorgia   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy